Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CYCC Ready For Major Swing Upward

|Includes: Cyclacel Pharmaceuticals, Inc. (CYCC)

Reported after hours favorable poster presentation on lead drug candidates positive anti-tumor signal for ovarian cancer. Dart hedge fund observed piling in over past several months.

Reiterate BUY and price conviction of $12. Focus stock for major partner news within 12 mos.